Market Place
Sourcing Support
Eurobio Buys Life Science Unit of Italy’s Voden Medical
01 Jul 2025 //
GLOBENEWSWIRE
Eurobio Scientific: EB Development rises above 90% threshold
19 May 2025 //
GLOBENEWSWIRE
Eurobio Scientific: 2024 annual results
28 Apr 2025 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC INCREASES ITS FOOTPRINT IN ITALY
12 Mar 2025 //
GLOBENEWSWIRE
Biovica Signs Agreement With Eurobio Scientific for 60% of Europe
05 Mar 2025 //
ACCESSWIRE
Eurobio Scientific Secures Majority Capital with 88.9% Ownership
19 Dec 2024 //
GLOBENEWSWIRE
Eurobio Scientific: RESULTS FOR THE 1ST HALF OF 2024
24 Sep 2024 //
GLOBENEWSWIRE
Eurobio Scientific Acquires EndoPredict® Test From Myriad Genetics
02 Aug 2024 //
GLOBENEWSWIRE
Myriad Genetics Sells EndoPredict Business To Eurobio Scientific
01 Aug 2024 //
GLOBENEWSWIRE
Eurobio Scientific Reports Solid First Half 2024 Results
31 Jul 2024 //
GLOBENEWSWIRE
Eurobio Scientific Announces Potential Tender Offer Agreement
31 Jul 2024 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC to Acquire ENDOPREDICT® Breast Cancer Test
06 May 2024 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
10 Apr 2024 //
GLOBENEWSWIRE
Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
30 Jan 2024 //
GLOBENEWSWIRE
Catherine Courboillet To Join Eurobio Scientific Board As An Independent Member
07 Nov 2023 //
GLOBENEWSWIRE
Eurobio Scientific - MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2023
30 Oct 2023 //
GLOBENEWSWIRE
Eurobio Scientific: GenDx reduces organ matching time to 3 hours
17 Oct 2023 //
GLOBENEWSWIRE
Eurobio Scientific : Results for the First Half of 2023
11 Oct 2023 //
GLOBENEWSWIRE
EUROBIO : ACCELERATION OF STRATEGIC DEPLOYMENT IN THE FIRST HALF OF 2023
24 Jul 2023 //
GLOBENEWSWIRE
Eurobio Scientific: Capital reduction through cancellation of treasury shares
11 Jul 2023 //
GLOBENEWSWIRE
Eurobio Scientific: all resolutions approved at the Annual General Meeting
16 Jun 2023 //
GLOBENEWSWIRE
Eurobio Scientific continues its international development
13 Jun 2023 //
GLOBENEWSWIRE
Eurobio Scientific becomes one of first European companies to obtain IVDR1 CE
23 May 2023 //
GLOBENEWSWIRE
Eurobio Scientific : 2022 ANNUAL RESULTS
05 Apr 2023 //
GLOBENEWSWIRE
Eurobio Scientific: Wietse Mulder, CEO of GenDx, holds a 2% stake
14 Feb 2023 //
GLOBENEWSWIRE
Eurobio formalises the appointment of Anne-Sophie Hérelle as Group CFO
08 Feb 2023 //
GLOBENEWSWIRE
EUORBIO SCIENTIFIC: 2022 TURNOVER OF ‚¬152.5M 15% CORE BUSINESS GROWTH AT €93M
23 Jan 2023 //
GLOBENEWSWIRE
Eurobio Scientific and Acobiom announce the signature of commercial agreement
22 Nov 2022 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENDX
17 Aug 2022 //
GLOBENEWSWIRE
Eurobio Scientific: FIRST HALF TURNOVER OF 83.6M MAINTAINED AT A HIGH LEVEL
25 Jul 2022 //
GLOBENEWSWIRE
Eurobio Scientific brings 2 new proprietary tests for diagnosis of new variants
20 Jun 2022 //
GLOBENEWSWIRE
Eurobio Scientific expands into Benelux by acquiring Biomedical Diagnostics NV
13 Jun 2022 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC: CLOSING OF THE STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM
18 May 2022 //
GLOBENEWSWIRE
CE mark for new test of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2
14 Apr 2022 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC: MAINTAINING HIGH LEVEL RESULTS IN 2021
06 Apr 2022 //
GLOBENEWSWIRE
Eurobio Scientific launches new test for detection of variants of SARS-CoV-2
09 Mar 2022 //
GLOBENEWSWIRE
Eurobio Scientific: Strategic Partnership With Nextstage AM
07 Feb 2022 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC LAUNCHES EXCLUSIVE DISTRIBUTION OF FIRST SALIVA SELF-TEST
11 Jan 2022 //
GLOBENEWSWIRE
EUROBIO SCIENTIFIC obtains CE marking for its proprietary test for Covid-19
13 Dec 2021 //
GLOBENEWSWIRE
